Figure 3From: Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants Reimbursement costs (monthly reimbursement expenditure in Euros) between 2003 and 2011 in France.Back to article page